Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
YM598 in hormone-refractory prostate cancer
NCT00048659Phase 2Terminated
- Sponsor
- Astellas Pharma
- Modality
- Small Molecules
- Countries
- 10
01
Overview
A Phase 2 trial of nebentan potassium in prostate cancer (PCa), sponsored by Astellas Pharma. Status: terminated.
02
Drugs
nebentan potassium
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00048659.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00048659.